Leadership

Michael Stevens is a growth-focused executive with 25+ years of experience in the healthcare industry, specializing in commercial strategy, marketing, and bringing disruptive technologies to market. He has built a career at the intersection of science, innovation, and execution—helping early-stage companies transform breakthrough ideas into scalable, commercially successful solutions.

Michael has led high-impact initiatives in the dental and biotech sectors, including the U.S. commercial launch and fundraising strategy for InnerView at Perimetrics and the emerging technology portfolio at Valkyrie BioScience. His expertise spans go-to-market development, national sales infrastructure, advisory board creation, M&A, capital strategy, and strategic partnerships.

Known for his ability to translate complex science into clear commercial value, Michael builds strong relationships with clinicians, investors, and industry leaders. He has collaborated with some of the most respected voices in dentistry and biotechnology to drive adoption, credibility, and market traction.

With a deep commitment to scientific integrity, operational excellence, and improving patient outcomes, Michael continues to focus on advancing ethical, data-driven solutions that elevate the standard of care across healthcare.

Dr. Douglas P. Hansen cofounded 3Dio (now Valkyrie BioSciences) in 2019 and served as President and CEO until September, 2025, when Michael Stevens came aboard.  He holds a Ph.D. in physics from BYU and an MS in Physics from UCLA.  From personal experience, he feels the most satisfying experience an entrepreneur can have is to see the customer’s passion for that new product that solves their problem for the first time.   

He is an innovation-focused executive with over 30 years of experience in bringing high-tech products and technologies to market, having had previous success in the international consumer electronics ecosystem and in long-term data storage.  He has broad experience in international business, building relationships with multiple major corporations in Europe and Asia; in technical business development, OEM marketing and sales,  in nano-scale and micro-scale device fabrication, testing, and evaluation; and in patents, business contracting, and corporate governance.  

Matthew J. Hunt Sr. is a dedicated sales and marketing professional with over 35 years of experience driving corporate initiatives and achieving sales targets for startups, turnarounds and Fortune 500 organizations. 

He has been directly responsible for new product launches, from concept to launch, and sales team development in the global capital equipment medical device industry. He has a proven track record of expanding and strengthening market share, customer support, and long-term business relationships to drive corporate profitability. In his work, he employs successful strategies to accelerate adoption in disruptive technologies.

Matthew brings wide-ranging dental knowledge, including distribution and direct sales organizations throughout the globe. His previous corporations include BIOLASE, Henry Schein, DMD and New Image, serving in various executive roles, including Vice President of Sales and Marketing, Director of Exclusives, General Manager.

Lou Shuman DMD CAGS is the president and CEO of Cellerant Consulting Group, a founder of DSO Technology Solutions, and co-founder of LightForce Orthodontics. He is professionally known for his expertise in bringing new technologies from all over the world into dentistry. 

Highly respected in the dental corporate and education community, he is a Venturer in Residence for the Harvard i-Lab, and a member of the Board of Directors at Lightforce Orthodontics, Sleep Architects. He is a member of the clinical advisory boards and editorial boards at Dentistry Today, Dental Products Report, Dental Economics, Orthodontic Practice US and Dental Sleep Practice Journal. Dr. Shuman is the creator of the prestigious Cellerant “Best of Class” Technology and “Best of Class” Hygiene Awards, unbiased nonprofit initiatives that, in conjunction with the leading experts in the field, select annually the most important technologies and products in the industry. 

He served as president of the Pride Institute for 6 years and Vice President of Clinical Education and Strategic Relations at Align Technology for 7 years. He has been chosen by Dentistry Today as a Leader in Consulting each year since 2006. Recently, he was awarded the American Mobile & Teledental Alliance’s highest honor, the Denobi Pinnacle Achievement Award, which recognizes an individual or company whose leadership and ongoing contributions have dramatically impacted the dental profession. 

Going forward, the award will be named in his honor and known as the Dr. Lou Shuman Denobi Pinnacle Achievement Award. He was also honored in 2021 as a Global Summits Institute Doctor-to-Doctor World’s Top 100 Doctors

With over 20 years of experience in regulatory affairs and quality management, Alicia Mszyca is a key figure in ensuring Valkyrie BioScience compliance with global medical device regulations. Her deep expertise in regulatory submissions, risk management, and product development plays a crucial role in bringing innovative, compliant solutions to the dental industry.

Dr. D. Clark Turner earned his B.S. in chemistry from Brigham Young University in 1985, and a Ph.D. in analytical chemistry from BYU in 1991. He is the founder of Turner Innovations, an early stage research and development company focused on bridging the gaps between fundamental research and commercialization of technologies based on that research. Previously, he was the founder and CEO of Aribex, and developer of the NOMAD handheld portable x-ray system. Dr. Turner has published over 20 scientific papers and presentations, and has been granted 12 patents with several patent applications pending. In 2011 he was awarded the Utah Governor’s Medal for Science and Technology in recognition of his accomplishments.

Todd R. Newman is a Certified Public Accountant and founding partner of Frost Dana Newman LLP, where he specializes in providing tax, accounting, and strategic advisory services to dental practices and other closely held professional organizations. Throughout his career, Todd has advised countless dental professionals on practice formation, tax planning, cash flow management, capital expenditures, and practice transitions, including acquisitions, affiliations, and succession planning.

Todd serves on the Board of Directors of Valkyrie BioScience, Inc. and is a member of the Company’s Audit Committee, where he applies his extensive experience in financial reporting, internal controls, and risk management to support strong corporate governance and financial oversight.

Todd began his career at PricewaterhouseCoopers and is a licensed CPA in Nevada and Utah. He is a member of the American Institute of Certified Public Accountants.

Jason Patrick Wood is a partner in the Law Firm of Wood & Delgado. Jason's primary emphasis is on business transactions for dentists and doctors: leases, purchase agreements, partnership agreements, shareholders agreements, corporations, associate agreements and other business-related legal needs. He has authored many articles relative to the business side of dentistry which have appeared in Dental Economics, CDA Journal, The New Dentist, Dentaltown Magazine, Colorado Dental Association Journal, Matsco's: Strategies For Success as well as numerous dental society newsletters. He is a moderator for Dentaltown on all forums related to the business side of dentistry and enjoys helping and educating doctors throughout the United States. Prior to joining Wood & Delgado, Jason worked in Washington, D.C. for the Speaker of the House in connection with Presidential and U.S. Congressional campaigns and thereafter he worked for the U.S. House of Representatives, drafting legislation for various House committees.

Todd R. Newman is a Certified Public Accountant and founding partner of Frost Dana Newman LLP, where he specializes in providing tax, accounting, and strategic advisory services to dental practices and other closely held professional organizations. Throughout his career, Todd has advised countless dental professionals on practice formation, tax planning, cash flow management, capital expenditures, and practice transitions, including acquisitions, affiliations, and succession planning.

Todd serves on the Board of Directors of Valkyrie BioScience, Inc. and is a member of the Company’s Audit Committee, where he applies his extensive experience in financial reporting, internal controls, and risk management to support strong corporate governance and financial oversight.

Todd began his career at PricewaterhouseCoopers and is a licensed CPA in Nevada and Utah. He is a member of the American Institute of Certified Public Accountants.

Scott Lamerand brings nearly 30 years of executive leadership and technical expertise in chemistry and dental materials to the Valkyrie board. His appointment aligns with Valkyrie’s mission to deliver future-ready imaging tools that bridge the gap between diagnosis and treatment.

"Scott’s proven track record of scaling healthcare manufacturing organizations and his deep understanding of the dental industry's clinical needs make him an invaluable addition to our leadership team," said Michael Stevens, CEO at Valkyrie BioScience. "As we continue to roll out our Lumos 3DX imaging platform and expand our AI-driven diagnostic capabilities, Scott’s strategic insights will be critical in driving our next phase of growth."

During his time at VistaApex, Lamerand was instrumental in shifting the company’s focus toward "total tooth" care solutions and fostering an innovation-first culture. Prior to becoming CEO, he founded Apex Dental Materials, which he grew into a premier industry player over 14 years. His career also includes leadership roles at US Can, Alcan Packaging and Loparex, where he managed technical R&D and commercial strategies.

Jared D Brokaw is an energetic technologist and business leader with over 25 years of experience delivering real business value with reliable, secure, and performant technology solutions that delight customers. Prior experience with organizational behavior and design in a variety of environments from startups to large enterprises with global presence make him a versatile member of the team.

Jared has built high-performing engineering organizations and led the delivery of many technology solutions across healthcare, medical device manufacturing, telecommunications, fintech, supply chain, facilities management, education, electronics manufacturing, industrial automation, simulation, and more. His background includes development of scalable software platforms, real-time systems, and complex distributed applications supporting businesses large and small. Jared is known for combining strategic leadership with deep and broad technical expertise to help organizations transform innovative ideas into commercially scalable product portfolios.

Christopher J. Walinski, DDS is an author, inventor and internationally recognized authority in laser dentistry and clinical photomedicine with more than 25 years of experience spanning private practice, academia, research and industry innovation.

Dr. Walinski holds one patent with multiple additional patents pending in the areas of biologic activation systems. His 2003 textbook on laser dentistry has been translated into more than ten languages which helped introduce laser technologies to clinicians worldwide.

A founding member of both the American Academy of Oral Systemic Health and the World Clinical Laser Institute, Dr. Walinski previously served as Executive Director of the World Clinical Laser Institute for 15 years. He has held academic appointments as an Associate Professor teaching dental technology (CBCT, scanning, 3D printing & milling) and esthetics at multiple U.S. dental schools and continues to lecture internationally on photomedicine, minimally-invasive therapies and regenerative clinical protocols.

In addition to his work in dentistry and medical technology, Dr. Walinski is the Founder and Director of the Dental Institute for Continuing Education (DICE) and he is a proud member of Sigma Xi, (the Scientific Research Honor Society) and his Fellowships include the International College of Dentists, Omicron Kappa Upsilon, The Royal Society of Medicine, The International Association for Laser Dentistry and the American Society for Lasers in Medicine and Surgery.